Kura Oncology, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 61.47 | -100% | -9.44 | -100% |
| P/S |
|
0 | 33.58 | -100% |
|
|
| P/BV |
|
2.52 | 4.79 | -47.34% |
|
|
| P/FCF |
|
-6.25 | 60.06 | -110.4% |
|
|
| Ev/Ebitda |
|
-5.96 | -17.26 | -65.5% |
|
|
| Ev/S |
|
0 | 22.49 | -100% |
|
|
| Ev/FCF |
|
-7.86 | 67.63 | -111.62% |
|
|
| E/P |
|
-0.1954 | 0.0168 | -1260.19% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
0 | 4.5 | -100% | 0 | 0% |
| ROE |
|
-38.42 | 9.39 | -509.1% |
|
|
| ROA |
|
-34 | 0.1519 | -22478.53% |
|
|
| ROIC |
|
-24.6 | 7.63 | -422.23% |
|
|
| ROS |
|
0 | -25.64 | -100% |
|
|
| ROCE |
|
-41.74 | 15.19 | -374.83% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0657 | -3.68 | -98.21% | -0.0779 | -15.68% |
| Nеt Debt/Ebitda |
|
0.122 | -4.07 | -103% |
|
|
| Debt/Ratio |
|
0.0241 | 0.199 | -87.87% |
|
|
| Debt/Equity |
|
4.34 | 1.67 | 160.36% |
|
|
| Debt/Net Income |
|
-0.071 | 10.34 | -100.69% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5399 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2331 | -100% |
|
|
| Average dividend growth |
|
0 | 1.07 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4916 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.32 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5399 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
0 | 76.2 | -100% | ||
| Growth impulse Ebitda in 5 years |
|
163.67 | 44.75 | 265.74% | ||
| Growth impulse Net Income in 5 years |
|
142.27 | -15.36 | -1026.24% | ||
| Growth impulse FCF in 5 years |
|
127.26 | -9.39 | -1455.27% | ||
| Growth impulse EPS in 5 years |
|
38.03 | -84.03 | -145.26% |
IP Score
3.68/10
